Antibody-Based Immunotoxins for Colorectal Cancer Therapy
Monoclonal antibodies (mAbs) are included among the treatment options for advanced colorectal cancer (CRC). However, while these mAbs effectively target cancer cells, they may have limited clinical activity. A strategy to improve their therapeutic potential is arming them with a toxic payload. Immun...
Guardado en:
Autores principales: | Laura Sanz, Raquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, Javier Lacadena, Alberto Anel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a4561937d03438ab89cf496388960d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
por: AVILA,ANA D, et al.
Publicado: (2007) -
DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
por: Hamid Hashemi Yeganeh, et al.
Publicado: (2021) -
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
por: Jean-Nicolas Tournier, et al.
Publicado: (2019) - Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Antibody Therapies for Large B-Cell Lymphoma
por: Novo M, et al.
Publicado: (2021)